Skip to main content
Equibles

Frazier Life Sciences Management, L.P.

Position in IBIO — iBio, Inc.

CIK 1892134 PALO ALTO, CA
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,418,567
-$293,020 QoQ
Shares Held
1,953,467
0.0% QoQ
Ownership
3.04%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#6
of 55 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. IBIO ranks #37 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 7,679,684 $899,060,605
2 NAMS
NewAmsterdam Pharma Co N.V.
 18,589,235 $623,725,004
3 ERAS
Erasca, Inc.
 24,975,188 $457,545,444
4 MBX
MBX Biosciences, Inc.
 6,652,013 $367,191,117
5 ARQT
Arcutis Biotherapeutics, Inc.
 9,874,511 $258,909,678
6 TRVI
Trevi Therapeutics, Inc.
 9,939,447 $185,370,686
7 KRYS
Krystal Biotech, Inc.
 481,307 $178,887,372
8 MAZE
Maze Therapeutics, Inc.
 5,032,915 $150,182,183

All Filings in IBIO

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,418,567 1,953,467
2026-03-31 $3,711,587 1,953,467
2025-12-31 $3,770,191 1,953,467